S-(2,5-Dimethylfuran-3-yl) furan-3-carbothioate
Common Name: |
S-(2,5-Dimethylfuran-3-yl) furan-3-carbothioate |
IUPAC Name: |
S-(2,5-dimethylfuran-3-yl) furan-3-carbothioate |
Molecular Formula: |
C11H10O3S |
SMILES: |
CC1=CC(=C(O1)C)SC(=O)C2=COC=C2 |
Inchi: |
1S/C11H10O3S/c1-7-5-10(8(2)14-7)15-11(12)9-3-4-13-6-9/h3-6H,1-2H3 |
Inchi Key: |
QVKDTUVQQAKGEO-UHFFFAOYSA-N |
Cas No: |
65505-16-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
222.26 |
Mass (g/mol) |
222.035 |
Molar Refractivity |
57.54 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
3 |
Rings |
2 |
TPSA |
68.65 |
Hetero Atoms |
3 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
10 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
79.00 to 83.00 @ 0.70 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.002 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.18 |
LogP |
3.256 |
iLOGP |
2.70 |
XLOGP3 |
2.80 |
WLOGP |
3.42 |
MLOGP |
0.86 |
ESOL Log S |
-3.28 |
ESOL Solubility (mg/ml) |
0.117 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.90 |
Ali Solubility (mg/ml) |
0.03 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-4.18 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.67 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.787 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.228 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |